ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders
- 16 September 2010
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 6 (10) , 1161-1174
Abstract
Importance of the field: The identification of xenobiotic metabolizing enzymes (i.e., CYP) and transporters (i.e., ABC transporters) (XMET) in the human brain, including the BBB, raises the question whether these transporters and enzymes have specific functions in brain physiology, neuropharmacology and toxicology. Areas covered in this review: Relevant literature was identified using PubMed search articles published up to March 2010. Search terms included ‘ABC transporters and P450 or CYP’, ‘drug metabolism, effect and toxicity’ and ‘neurodegenerative disease (Alzheimer and Parkinson diseases)’ restricted to the field of ‘brain or human brain’. What the reader will gain: This review aims to provide a better understanding of XMET functions in the human brain and show their pharmacological importance for improving drug delivery and efficacy and also for managing their side effects. Finally, the impact of brain XMET activity during neurodegenerative processes is discussed, giving an opportunity to identify new markers of human brain diseases. Take home message: During the last 2 decades, much evidence concerning the specific distribution patterns of XMET, their induction by xenobiotics and endobiotics and their genetic variations have made cerebral ABC transporters and CYP enzymes key elements in the way individual patients respond to centrally acting drugs.Keywords
This publication has 93 references indexed in Scilit:
- Xenobiotic-Metabolizing Enzymes and Transporters in the Normal Human Brain: Regional and Cellular Mapping as a Basis for Putative Roles in Cerebral FunctionDrug Metabolism and Disposition, 2009
- ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood–brain barrierJournal of Neurochemistry, 2008
- Brain Drug-Metabolizing Cytochrome P450 Enzymes are Active In Vivo, Demonstrated by Mechanism-Based Enzyme InhibitionNeuropsychopharmacology, 2008
- Mammalian cytochromes P450—Importance of tissue specificityBiochimica et Biophysica Acta (BBA) - General Subjects, 2007
- CYP2D6 polymorphism, pesticide exposure, and Parkinson's diseaseAnnals of Neurology, 2004
- Progesterone Oxidation by Cytochrome P450 2D Isoforms in the BrainEndocrinology, 2001
- Radical cation intermediates in N-dealkylation reactionsXenobiotica, 1995
- Progress in PsychiatryNew England Journal of Medicine, 1993
- 2-Hydroxylation of estrogens in the brain participates in the initiation of the preovulatory LH surge in the ratBiochemical and Biophysical Research Communications, 1980
- On the occurrence of cytochrome P-450 and aryl hydrocarbon hydroxylase activity in rat brain.Journal of Experimental Medicine, 1977